Alzheimer’s disease affects nearly 6 million Americans. It’s the sixth leading cause of death among all adults and the fifth leading cause for those aged 65 or older, and the problem is only getting ...
Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the ...
Cognito Therapeutics has spent the better part of the last decade developing neuromodulation technology that it claims could stop and even reverse the progression of Alzheimer’s and other ...
Christian Howell, CEO of Cognito Therapeutics, sits down with Nasdaq’s Kristina Ayanian to discuss the company’s breakthrough approach to treating Alzheimer’s using light and sound stimulation. From ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results